GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » Price-to-Owner-Earnings

CellCura ASA (FRA:C6L) Price-to-Owner-Earnings : (As of Jun. 04, 2024)


View and export this data going back to . Start your Free Trial

What is CellCura ASA Price-to-Owner-Earnings?

As of today (2024-06-04), CellCura ASA's share price is €0.02. CellCura ASA does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for CellCura ASA's Price-to-Owner-Earnings or its related term are showing as below:


FRA:C6L's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.035
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-04), CellCura ASA's share price is €0.02. CellCura ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2014 was €-0.40. Therefore, CellCura ASA's PE Ratio for today is At Loss.

As of today (2024-06-04), CellCura ASA's share price is €0.02. CellCura ASA's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.40. Therefore, CellCura ASA's PE Ratio without NRI for today is At Loss.


CellCura ASA Price-to-Owner-Earnings Historical Data

The historical data trend for CellCura ASA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Price-to-Owner-Earnings Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CellCura ASA's Price-to-Owner-Earnings

For the Biotechnology subindustry, CellCura ASA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellCura ASA's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where CellCura ASA's Price-to-Owner-Earnings falls into.



CellCura ASA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

CellCura ASA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.02/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA  (FRA:C6L) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


CellCura ASA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (FRA:C6L) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines